» Articles » PMID: 35992085

Multifaceted Role of RNA Editing in Promoting Loss-of-function of PODXL in Cancer

Overview
Journal iScience
Publisher Cell Press
Date 2022 Aug 22
PMID 35992085
Authors
Affiliations
Soon will be listed here.
Abstract

PODXL, a protein that is dysregulated in multiple cancers, plays an important role in promoting cancer metastasis. In this study, we report that RNA editing promotes the inclusion of a alternative exon. The resulting edited PODXL long isoform is more prone to protease digestion and has the strongest effects on reducing cell migration and cisplatin chemoresistance among the three PODXL isoforms (short, unedited long, and edited long isoforms). Importantly, the editing level of the recoding site and the inclusion level of the alternative exon are strongly associated with overall patient survival in Kidney Renal Clear Cell Carcinoma (KIRC). Supported by significant enrichment of exonic RNA editing sites in alternatively spliced exons, we hypothesize that exonic RNA editing sites may enhance proteomic diversity through alternative splicing, in addition to amino acid changes, a previously under-appreciated aspect of RNA editing function.

Citing Articles

ADAR-Mediated A>I(G) RNA Editing in the Genotoxic Drug Response of Breast Cancer.

Bernal Y, Duran E, Solar I, Sagredo E, Armisen R Int J Mol Sci. 2024; 25(13).

PMID: 39000531 PMC: 11242177. DOI: 10.3390/ijms25137424.


RNA Editing in Cancer Progression.

Frezza V, Chellini L, Del Verme A, Paronetto M Cancers (Basel). 2023; 15(21).

PMID: 37958449 PMC: 10648226. DOI: 10.3390/cancers15215277.

References
1.
Lee H, Kong J, Lee S, Kim A . Radiation-Induced Overexpression of TGFβ and PODXL Contributes to Colorectal Cancer Cell Radioresistance through Enhanced Motility. Cells. 2021; 10(8). PMC: 8393946. DOI: 10.3390/cells10082087. View

2.
Zuker M . Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003; 31(13):3406-15. PMC: 169194. DOI: 10.1093/nar/gkg595. View

3.
Miller M, Sullivan R, Lauffenburger D . Molecular Pathways: Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of Cancer. Clin Cancer Res. 2016; 23(3):623-629. PMC: 5290119. DOI: 10.1158/1078-0432.CCR-16-0869. View

4.
Han S, Kim H, Shin J, Jeong E, Lee W, Kim K . RNA editing in RHOQ promotes invasion potential in colorectal cancer. J Exp Med. 2014; 211(4):613-21. PMC: 3978269. DOI: 10.1084/jem.20132209. View

5.
Amo L, Tamayo-Orbegozo E, Maruri N, Buque A, Solaun M, Rinon M . Podocalyxin-like protein 1 functions as an immunomodulatory molecule in breast cancer cells. Cancer Lett. 2015; 368(1):26-35. DOI: 10.1016/j.canlet.2015.06.029. View